Drugs / Spikogen
Spikogen
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06355232 | May 2024 → Dec 2025 overdue | COVID-19, influenza | Vaxine Pty Ltd | Recruiting | No outcome recorded |
| Phase 1 | NCT04428073 | Jul 2020 → Jul 2021 | COVID-19 | GeneCure Biotechnologies | Unknown | No outcome recorded |
| Phase 1 | NCT04453852 | Jun 2020 → Feb 2021 | COVID-19 | Vaxine Pty Ltd | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT05542862 | Sep 2022 → Dec 2023 | COVID-19 | Vaxine Pty Ltd | Completed | No outcome recorded |
| Phase 3 | NCT05279456 | Aug 2022 → Dec 2023 | COVID-19 | Vaxine Pty Ltd | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05148871 Comparator | Mar 2022 → Feb 2023 overdue | COVID-19 | Vaxine Pty Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spikogen | “SpikoGen® vaccine was licensed for use in the Middle East as a primary vaccine course in adults in October 2021.” NCT06355232 ↗4“Spikogen® vaccine, also known as Covax-19™ in Australia, is an adjuvanted recombinant protein Covid-19 vaccine” NCT05279456 ↗ “Spikogen® vaccine is an Advax-CpG55.2 adjuvanted recombinant protein vaccine” NCT06355232 ↗ |
| Known as | Covax-19 | “Spikogen, also known under the Covax-19 tradename in Australia, is based on recombinant SARS-COV-2 spike protein” NCT05148871 ↗3“Spikogen® vaccine, also known as Covax-19™ in Australia, is an adjuvanted recombinant protein Covid-19 vaccine” NCT05279456 ↗ “This is a study to test a new vaccine (Covax-19) against COVID-19.” NCT04453852 ↗ |
| Known as | Spikogen vaccine | “Spikogen vaccine” NCT05279456 ↗ |
| Modality | Vaccine | “Therapeutic vaccine for SARS-CoV-2 infection” NCT04428073 ↗ |
| Route | Intramuscular | “sterile solution for intramuscular injection” NCT04453852 ↗ |